United States (US) Irritable Bowel Syndrome (IBS) Market (2025-2031) | Outlook, Forecast, Segmentation, Growth, Size & Revenue, Analysis, Industry, Companies, Competitive Landscape, Share, Trends, Value

Market Forecast By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Others), By Medical Condition (IBS-Constipation, IBS-diarrhea, Mixed), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) And Competitive Landscape
Product Code: ETC9968610 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Irritable Bowel Syndrome (IBS) Market Outlook
  • Market Size of United States (US) Irritable Bowel Syndrome (IBS) Market, 2024
  • Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market, 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Revenues & Volume for the Period 2021- 2031
  • United States (US) Irritable Bowel Syndrome (IBS) Market Trend Evolution
  • United States (US) Irritable Bowel Syndrome (IBS) Market Drivers and Challenges
  • United States (US) Irritable Bowel Syndrome (IBS) Price Trends
  • United States (US) Irritable Bowel Syndrome (IBS) Porter's Five Forces
  • United States (US) Irritable Bowel Syndrome (IBS) Industry Life Cycle
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Drug Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Lubiprostone for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Linaclotide for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Eluxadoline for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Rifaximin for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Alosetron for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Medical Condition for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-Constipation for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-diarrhea for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Mixed for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Homecare Settings for the Period 2021- 2031
  • United States (US) Irritable Bowel Syndrome (IBS) Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By Medical Condition
  • Market Opportunity Assessment By Distribution Channel
  • Market Opportunity Assessment By End-Users
  • United States (US) Irritable Bowel Syndrome (IBS) Top Companies Market Share
  • United States (US) Irritable Bowel Syndrome (IBS) Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Irritable Bowel Syndrome (IBS) Company Profiles
  • United States (US) Irritable Bowel Syndrome (IBS) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Irritable Bowel Syndrome (IBS) Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle

3.4 United States (US) Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces

3.5 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F

3.7 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.8 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 United States (US) Irritable Bowel Syndrome (IBS) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Irritable Bowel Syndrome (IBS) Market Trends

6 United States (US) Irritable Bowel Syndrome (IBS) Market, By Types

6.1 United States (US) Irritable Bowel Syndrome (IBS) Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F

6.1.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F

6.1.5 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F

6.1.6 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F

6.1.7 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F

6.1.8 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F

6.2 United States (US) Irritable Bowel Syndrome (IBS) Market, By Medical Condition

6.2.1 Overview and Analysis

6.2.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F

6.2.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F

6.2.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F

6.3 United States (US) Irritable Bowel Syndrome (IBS) Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.3.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4 United States (US) Irritable Bowel Syndrome (IBS) Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United States (US) Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F

7 United States (US) Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics

7.1 United States (US) Irritable Bowel Syndrome (IBS) Market Export to Major Countries

7.2 United States (US) Irritable Bowel Syndrome (IBS) Market Imports from Major Countries

8 United States (US) Irritable Bowel Syndrome (IBS) Market Key Performance Indicators

9 United States (US) Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment

9.1 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F

9.3 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.4 United States (US) Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 United States (US) Irritable Bowel Syndrome (IBS) Market - Competitive Landscape

10.1 United States (US) Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024

10.2 United States (US) Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All